Peretz Partensky

Peretz Partensky is the Co-founder and CEO of ImmuneBridge, a biotech company developing allogeneic immunotherapies for cancer.12 He has a Ph.D. in Biophysics from UC San Francisco and has co-founded multiple successful companies.12

Prior to ImmuneBridge, Partensky co-founded:

1. Cheetah Technologies: A platform connecting restaurants and suppliers with next-day delivery.1
2. Sourcery: A B2B commerce and payments platform for the food industry, which raised $11M and was later acquired.1

Partensky is also a Venture Partner at Pioneer Fund, where he works with the YC Alumni Community to invest in YC Companies, with expertise in healthcare and life sciences.1

His educational background includes:

• Ph.D. in Biophysics from UC San Francisco
• MPhil in European Literature from the University of Cambridge
• BA in Physics, Math, and English from Brandeis University1

Partensky is described as a YC founder, team builder, serial entrepreneur, and immunology devotee.1 He started ImmuneBridge in July 2020, focusing on developing cell therapies for immune systems in need.13